Table 3.

Sustained virological response by treatment group

	PEG-IFN + RBV – 24 weeks (n = 90), n (%)	PEG-IFN + RBV – 48 weeks (n = 219), n (%)	Total (n = 309), n (%)
All patients	58 (64.4)	93 (42.5)	151 (48.9)
Treatment status at baseline
Treatment-naïve	52/80 (65.0)	78/184 (42.4)	130/264 (49.3)
Relapser	6/10 (60.0)	15/33 (45.5)	21/43 (48.8)
Baseline viral load (IU/mL)
0–400 000	29/38 (76.3)	49/87 (56.3)	78/125 (62.4)
>400 000	29/52 (55.8)	44/132 (33.3)	73/184 (39.7)
0–800 000	35/55 (63.6)	71/151 (47.0)	106/206 (51.5)
>800 000	23/35 (65.7)	22/68 (32.4)	45/103 (43.7)